Literature DB >> 7452391

Theophylline disposition in infancy.

E G Nassif, M M Weinberger, D Shannon, S F Guiang, L Hendeles, D Jimenez, E Ekwo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7452391

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

Review 1.  Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.

Authors:  J T Gilman
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

2.  The population pharmacokinetics of theophylline in neonates and young infants.

Authors:  E S Moore; R G Faix; R C Banagale; T H Grasela
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

Review 3.  Sustained release theophylline preparations. Practical recommendations for prescribing and therapeutic drug monitoring.

Authors:  A Glynn-Barnhart; M Hill; S J Szefler
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

4.  Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation.

Authors:  Hussain Mulla; Fazal Nabi; Sanjiv Nichani; Graham Lawson; R K Firmin; David R Upton
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

Review 5.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 6.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

7.  Pharmacokinetics of theophylline in infants with bronchiolitis.

Authors:  T G Franko; D A Powell; M C Nahata
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Chlorpromazine disposition in relation to age in children.

Authors:  M Furlanut; P Benetello; M Baraldo; G Zara; G Montanari; F Donzelli
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.